SPM
MNTA

Symmetry Peak Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Symmetry Peak Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-6,500
Closed -$216K – 128
2020
Q2 		$216K Buy
+6,500
New +$207K 0.17% 69

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OP
Omni Partners London, United Kingdom $2.03B AUM 126.33% 1-Year Est. Return

Symmetry Peak Management's MNTA Position: Q3 2020 in Review

Symmetry Peak Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q3 2020, closing a stake of 6,500 shares — an estimated $216K sold.

Symmetry Peak Management first reported a position in MNTA in Q2 2020 and held it in 1 quarter. The position peaked at $216K in Q2 2020. 211 funds tracked by Wall St. Rank hold MNTA as of Q3 2020.

  • Symmetry Peak Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
  • Symmetry Peak Management sold 6,500 Momenta Pharmaceuticals, Inc. shares in Q3 2020, an estimated $216K.
  • Symmetry Peak Management first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
  • Symmetry Peak Management's Momenta Pharmaceuticals, Inc. position peaked at $216K in Q2 2020.
  • 211 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q3 2020.

Based on Symmetry Peak Management's 13F filing for Q3 2020, filed 16 Nov 2020.